– UTERINE SARCOMAS (LEIOMYOSARCOMA, ENDOMETRIAL STROMAL SARCOMA, ADENOSARCOMA) (ICD‐O‐3 C53, 54, 55)


UTERUS – UTERINE SARCOMAS (LEIOMYOSARCOMA, ENDOMETRIAL STROMAL SARCOMA, ADENOSARCOMA) (ICD‐O‐3 C53, 54, 55)


The definitions of the T, N, and M categories correspond to the FIGO stages. Both systems are included for comparison.


Rules for Classification


The classification applies to sarcomas except for carcinosarcoma, which is classified as carcinoma of the endometrium. There should be histological confirmation and division of cases by histologic type.


The FIGO stages are based on surgical staging. TNM stages are based on clinical and/or pathological classification.


Anatomical Subsites (Fig . 424)



  1. Cervix uteri (C53)
  2. Isthmus uteri (C54.0)
  3. Fundus uteri (C54.3)

Histological Types of Tumours












Leiomyosarcoma ICD‐O‐3 M 8890/3
Endometrial stromal sarcoma ICD‐O‐3 M 8930/3
Endometrial stromal sarcoma, low grade Adenosarcoma ICD‐O‐3 M 8931/3ICD‐O‐3 M 8933/3

Regional Lymph Nodes (Fig. 425)


The regional lymph nodes are the pelvic (hypogastric [obturator, internal iliac] (3), common (5) and external (4) iliac, parametrial (2), and sacral (6)) and the para‐aortic nodes (7).


Leiomyosarcoma, Endometrial stromal sarcoma


TNM Clinical Classification


T – Primary Tumour
























































TNM Categories FIGO Stages Definition
T1 I Tumour limited to the uterus
 T1a  IA  Tumour 5 cm or less in greatest dimension (Fig. 442)
 T1b  IB  Tumour more than 5 cm in greatest dimension (Fig. 443)
T2 II Tumour extends beyond the uterus, within the pelvis (Fig. 444)
 T2a  IIA  Tumour involves adnexa (Fig. 444)
 T2b  IIB  Tumour involves other pelvic tissues (Fig. 445)
T3 III Tumour infiltrates abdominal tissues
 T3a  IIIA  One site (Fig. 446)
 T3b  IIIB  More than one site (Fig. 447)
N1 IIIC Metastasis to regional lymph nodes
T4 IVA Tumour invades bladder or rectum (Fig. 448)
M1 IVB Distant metastasis

Note
Simultaneous tumours of the uterine corpus and ovary/pelvis in association with ovarian/pelvic endometriosis should be classified as independent primary tumours.

Schematic illustration of tumour 5 cm or less in greatest dimension.

Fig. 442

Schematic illustration of tumour more than 5 cm in greatest dimension.

Fig. 443

Schematic illustration of tumour extends beyond the uterus, within the pelvis.

Fig. 444

Schematic illustration of tumour involves other pelvic tissues.

Fig. 445

Schematic illustration of One site for IIIA FIGO stage in T3 category.

Fig. 446

Schematic illustration of more than one site for IIIB FIGO stage in T3 category.

Fig. 447

Schematic illustration of tumour invades bladder or rectum.

Fig. 448


Adenosarcoma


TNM Clinical Classification


T – Primary Tumour




























































TNM Categories FIGO Stage Definition
T1 I Tumour limited to the uterus
ΌT1a ΌIA ΌTumour limited to the endometrium/endocervix (Fig. 449)
ΌT1b ΌIB ΌTumour invades to less than half of the myometrium (Fig. 450)
ΌT1c ΌIC ΌTumour invades more than half of the myometrium (Fig. 451)
T2 II Tumour extends beyond the uterus, within the pelvis
ΌT2a ΌIIA ΌTumour involves adnexa (Fig. 444)
ΌT2b ΌIIB ΌTumour involves other pelvic tissues (Fig. 445)
T3 III Tumour involves abdominal tissues
ΌT3a ΌIIIA ΌOne site (Fig. 446)
ΌT3b ΌIIIB ΌMore than one site (Fig. 447)
N1 IIIC Metastasis to regional lymph nodes
T4 IVA Tumour invades bladder or rectum (Fig. 448)
M1 IVB Distant metastasis

Note
Simultaneous tumours of the uterine corpus and ovary/pelvis in association with ovarian/pelvic endometriosis should be classified as independent primary tumours.

Schematic illustration of tumour limited to the endometrium or endocervix.

Fig. 449

Schematic illustration of tumour invades to less than half of the myometrium.

Fig. 450

Schematic illustration of tumour invades more than half of the myometrium.

Fig. 451


N – Regional Lymph Nodes












NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Regional lymph node metastasis

M – Distant Metastasis









M0 No distant metastasis
M1 Distant metastasis (excluding adnexa, pelvic and abdominal tissues)

pTNM Pathological Classification


The pT and pN categories correspond to the T and N categories.






pM1 Distant metastasis microscopically confirmed

Note
pM0 and pMX are not valid categories.


Summary

Tags:
Dec 15, 2022 | Posted by in ONCOLOGY | Comments Off on – UTERINE SARCOMAS (LEIOMYOSARCOMA, ENDOMETRIAL STROMAL SARCOMA, ADENOSARCOMA) (ICD‐O‐3 C53, 54, 55)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access